Health and wellness specialist The Calmer Co (ASX:CCO) announces US practitioner supplements brand Metagenics has launched MetaSleep: a new product that uses the company’s...
Small-cap biotech Alterity Therapeutics (ASX:ATH) has pocketed $1.3 million from the first tranche of its $4.8 million share placement to help fund its ongoing...
Clinical dermatology specialist Botanix Pharmaceuticals (ASX:BOT) is raising $13.5 million through a share placement to support the launch of its lead Sofdra product in...
Clinical-stage biotechnology company Immutep (ASX:IMM) has expanded its INSIGHT-003 trial to 4 sites across Germany, including the University Clinic of Ruhr Universitȁt Bochum and...
Invex Therapeutics (ASX:IXC) has been granted a European patent for the use of Exenatide in Hydrocephalus, which is a neurological disorder associated with an...
Life-science company Invion (ASX:IVX) has taken a ‘significant’ step towards starting clinical trials by reaching a manufacturing milestone for its INV043 drug substance, used...
Austco Healthcare (ASX:AHC) has been awarded a $3.8 million contract to refresh its Tacera Nurse Call platform for the Jurong Health Campus in Singapore.
The...
Emyria (ASX:EMD) has received approval from Health Canada to begin importating MDMA into Australia.
The $23.36 million market capitalisation company has received all necessary Health...
IMEXHS (ASX:IME) subsidiary RIMAB has secured a $1.6 million radiology services contract with the San Carlos Hospital Foundation in the southern region of Bogota,...
Imricor Medical Systems (ASX:IMR) is activating a new invasive cardiovascular magnetic resonance (iCMR) imaging site in Zagreb, Croatia.
The Clinical Hospital Dubrava has placed an...
IMEXHS (ASX:IME) subsidiary RIMAB has secured a $2 million contract with Colombia’s National Police Force to provide radiology outsourcing services to 48,000 patients.
Under the...
Ovarian cancer diagnostics company Cleo Diagnostics (ASX:COV) has finalised the selection of biomarkers to be used in its ovarian cancer test kit.
The $23.13 million...
ECS Botanics (ASX:ECS) has secured a $24 million offtake agreement to supply medicinal cannabis dried flower over the next 5 years to Perth-based MediCann...
Emyria (ASX:EMD) has secured the supply of locally-available MDMA — meaning it’s now set to being dosing for its MDMA-assisted therapy (MDMA-AT) trial for...
Clinical stage medicine developer AdAlta (ASX:1AD) has completed the enrolment of healthy volunteers into its AD-214 phase one extension study.
The $9.71 million market capitalisation...
The Hydration Pharmaceuticals Company (ASX:HPC), also known as Hydralyte North America, has completed an entitlement offer to raise $2.7 million for marketing and growth...
Biotechnology and pharmaceutical company BPH Global (ASX:BP8) has entered into a legally binding joint venture (JV) agreement with Singapore-based Chemokine Yuesheng to develop 2...
Australian software company InteliCare (ASX:ICR) has executed a non-binding heads of agreement (HoA) with JNC Technologies Group to leverage its tech platform to JNC’s...